Aeromonas hydrophila (A. hydrophila)

Aeromonas hydrophila is a heterotrophic, Gram-negative, rod-shaped bacterium primarily found in aquatic environments (StatPearls, 2023). While it is a significant pathogen in fish and amphibians, it is also an opportunistic human pathogen capable of causing a range of illnesses, including gastroenteritis, skin and soft tissue infections, and life-threatening septicemia (CDC, 2022). The pathogenicity of A. hydrophila is mediated by a variety of virulence factors, such as aerolysin, cytotoxic enterotoxins, and various extracellular enzymes like proteases and lipases (PubMed, 2021). In clinical settings, it is often resistant to many common antibiotics, including penicillins and some cephalosporins, due to the production of multiple beta-lactamases (NIH, 2020). Treatment typically involves fluoroquinolones, aminoglycosides, or third-generation cephalosporins, which target essential bacterial processes like DNA replication and protein synthesis (Journal of Clinical Microbiology, 2019). Because Aeromonas hydrophila is a whole organism rather than a specific protein or receptor, it is classified as a pathogen rather than a molecular drug target (Microbiology Society, 2022). However, specific components of the bacterium, such as its DNA gyrase or ribosomes, serve as the actual molecular targets for antimicrobial therapy (Nature Reviews Microbiology, 2020). Monitoring for this organism often involves culture-based methods or molecular techniques like PCR to detect specific virulence genes (Clinical Infectious Diseases, 2021).

Other names

Bacillus hydrophilusProteus hydrophilusAeromonas punctataAeromonas liquefaciensA. hydrophila

Antibiotics used against Aeromonas hydrophila function through various mechanisms: fluoroquinolones inhibit DNA gyrase and topoisomerase IV, preventing DNA replication; aminoglycosides and tetracyclines inhibit protein synthesis by binding to ribosomal subunits; and beta-lactams (cephalosporins and carbapenems) inhibit peptidoglycan synthesis in the bacterial cell wall.